Immunostaining of the recurrent tumor (the primary was unavailable for comparison) was scored as PR (3+, 10% of viable epithelial cells), ERα (3+, 100% of viable cells), and GPER (3+, less than 10% of viable cells, Figures 6(f)–6(i)). Here, ESR1 is linked to neoplasm.